Applied Digital Corporation filed an 8-K on November 6, 2026, reporting the final voting results from its 2026 Annual Meeting of Stockholders held on November 4, 2026, covering four proposals including director elections, auditor ratification, and an advisory compensation vote.
Ziff Davis, Inc. filed a Current Report on Form 8-K on November 5, 2026, disclosing preliminary unaudited financial results for the third quarter ended September 30, 2026, and announcing an earnings conference call scheduled for November 6, 2026.
Cannae Holdings, Inc. filed a current report on November 6, 2026, disclosing that two directors informed the Board on November 4, 2026 of their intention not to stand for re-election at the company's December 11, 2026 Annual Meeting of Shareholders.
Align Technology, Inc. filed a Form 8-K on November 6, 2026, disclosing that on November 5, 2026, it entered into a $270 million accelerated share repurchase agreement with Goldman Sachs & Co. LLC.
Nuvve Holding Corp. filed a Form 8-K on November 5, 2026, disclosing the appointment of Andrew Ritter and Wobbie Ploegsma to its Board of Directors, effective December 21, 2026.
Big Digital Energy, Inc. filed a Form 8-K on November 6, 2026, disclosing the issuance of a press release on November 5, 2026 announcing financial results for the three and nine months ended September 30, 2026, alongside the release of an investor presentation furnished …
Passage Bio, Inc. filed a Form 8-K on November 6, 2026, reporting the results of a Special Meeting of Stockholders held on November 5, 2026, at which stockholders approved equity compensation plans and merger-related proposals connected to the company's planned combination with Remix Therapeutics, …
EVERTEC, Inc. filed a Form 8-K on November 6, 2026, disclosing that its subsidiary Evertec Group, LLC entered into a seventh amendment to its credit agreement on November 5, 2026, refinancing existing debt facilities and expanding its revolving credit capacity.
K&F Growth Acquisition Corp. II filed a Form 8-K on November 6, 2026, reporting the results of an extraordinary general meeting held November 4, 2026, at which shareholders approved an extension of the initial business combination deadline and ratified the company's independent auditor.
Onconetix, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing that the company and its counterparties executed the First Amendment to the Share Exchange Agreement with Realbotix on November 4, 2026, modifying several key terms of the transaction originally signed …